---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-134349"
form_type: "8-K"
ticker: "IRON"
cik: "0001816736"
company_name: "Disc Medicine, Inc."
filed_at: "2024-12-09T23:59:59+00:00"
generated_at: "2026-05-29T05:45:36.130589+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "low"
source: SEC EDGAR
---

# Disc Medicine reviews ASH 2024 clinical data for bitopertin, DISC-0974, DISC-3405

## Summary
- Company held conference call on Dec 8 to review data presented at ASH Annual Meeting.
- Operational plans discussed alongside clinical updates for three pipeline programs.
- Specific data results or guidance not provided in the 8-K filing; only presentation referenced.
- Programs include bitopertin, DISC-0974, and DISC-3405.

## SEC filing metadata
- accession: 0000950170-24-134349
- form_type: 8-K
- ticker: IRON
- cik: 0001816736
- company_name: Disc Medicine, Inc.
- filed_at: 2024-12-09T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: low
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1816736/000095017024134349/0000950170-24-134349-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1816736/000095017024134349/iron-20241208.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-134349
- JSON: https://secwatch.observer/filing/0000950170-24-134349.json
- Plain text: https://secwatch.observer/filing/0000950170-24-134349.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.